Capital raising

How Can Founders Discuss a Pending Patent or Trade Secret With Potential Investors?

Short answer. Describe the status accurately, separating public information from what remains confidential. Explain the business value without sharing technical details investors do not need. Before sharing claims, documents, or demonstrations, have counsel review patent status, ownership, confidentiality terms, and trade secret protections.

When discussing a pending patent or trade secret, describe its status precisely and take care with what you disclose. Investors need to understand how the intellectual property supports the business, but an early conversation rarely requires every technical detail.

Describe Status Accurately

Use language that matches the records. If an application is pending, call it pending and explain which parts are public and which remain confidential. Do not suggest that a patent has been granted or that an application guarantees protection. For a trade secret, describe its business function without revealing the secret itself.

Confirm who owns the relevant work and whether founders, employees, contractors, universities, customers, or other parties have related rights or obligations. Have your attorney review status and ownership before making legal claims in investor materials. Keep descriptions consistent across the pitch deck, website, data room, and spoken presentations.

Explain the Commercial Value

Describe the problem the IP addresses and how it supports the product or service. Explain its value to customers or company operations. You can discuss development stage and use cases, along with the IP's role in your strategy, without providing source code, formulas, manufacturing instructions, or other sensitive details.

If an investor needs more to assess the opportunity, ask what question the requested material would answer. Consider whether a demonstration, summary, redacted document, or supervised review will provide enough evidence. Share technical details in stages, after the company has reviewed the request and applicable confidentiality terms.

Prepare Safeguards With Counsel

Before the meeting, identify confidential material and agree internally on what may be discussed. Ask counsel to review confidentiality terms and the planned disclosure. Trade secret protection can depend on how information is handled, so avoid broad distribution or informal forwarding. Use controlled access and identify recipients. Mark sensitive documents and keep a record of each version shared.

A patent filing and a trade secret raise different questions. The right approach depends on the facts. Talk with your attorney about filing status, disclosure timing, ownership, or obligations to third parties. Do not promise exclusivity, enforceability, or protection unless counsel has confirmed the wording.

Keep the Conversation Clear

Investors should leave understanding what the IP does for the business and what stage it is at. They should also know what remains confidential. If you cannot confirm a detail, say so and follow up after checking the source. For preparation, see how to respond to investor requests for unverified information and safeguards for sharing sensitive IP.

Apply the same discipline to your diligence process. A controlled investor data room can help manage approved materials and access. When several investors are reviewing the company, use a consistent process for managing confidentiality across those conversations.

You want everyone to treat you as a credible expert in your niche instead of you having to constantly reach out cold to investors while unarmed with these pieces of intellectual property.

Richard C. Wilson, Capital Raising

Sources: Capital Raising. Informational only, not financial, legal or tax advice.